Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 106, Issue 11, Pages 1766-1771
Publisher
Springer Nature
Online
2012-04-27
DOI
10.1038/bjc.2012.165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors
- (2012) Dan M. Patterson et al. CLINICAL CANCER RESEARCH
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent
- (2010) J D Lickliter et al. BRITISH JOURNAL OF CANCER
- Fit-for-purpose biomarker method validation in anticancer drug development
- (2010) Jeffrey Cummings et al. DRUG DISCOVERY TODAY
- Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer
- (2010) Luigi De Petris et al. EUROPEAN JOURNAL OF CANCER
- Utilization of cytokeratin-based biomarkers for pharmacodynamic studies
- (2010) Stig Linder et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503
- (2010) Lori Rice et al. MICROVASCULAR RESEARCH
- Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
- (2009) Jian-Mei Hou et al. AMERICAN JOURNAL OF PATHOLOGY
- Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response
- (2009) L C Scott et al. BRITISH JOURNAL OF CANCER
- Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon α: possible use as a surrogate marker
- (2009) M B Fisher et al. CANCER GENE THERAPY
- Preclinical evaluation of vascular-disrupting agents in Ewing’s sarcoma family of tumours
- (2009) Surita Dalal et al. EUROPEAN JOURNAL OF CANCER
- Cytokeratins 8 and 18 in adult human corneal endothelium
- (2009) Stanislava Merjava et al. EXPERIMENTAL EYE RESEARCH
- Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors
- (2009) Banu Ozturk et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Specificity and Accuracy Data for Ligand-binding Assays for Macromolecules Should be Interpreted with Caution
- (2008) John W. A. Findlay AAPS Journal
- Optimisation of circulating biomarkers of cell death for routine clinical use
- (2008) A. Greystoke et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now